Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure

Trial Profile

Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Levosimendan (Primary) ; Dobutamine
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms ELDOR
  • Most Recent Events

    • 01 Feb 2017 Planned End Date changed from 1 May 2015 to 1 Dec 2017.
    • 01 Feb 2017 Planned primary completion date changed from 1 Apr 2015 to 1 Dec 2017.
    • 04 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top